reference/6112153

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6112153

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	11
pageRange	e0240801-
publicationName	PLOS ONE
startingPage	e0240801
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9a1204a49026b78f9fde029205902961 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_623ab85ff7f4a1d1ab5314cf275f271c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_76914e34b56f1795ce2228f60d0261c9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Han C, Yu G, Mao Y, Song S, Li L, Zhou L, Wang Z, Liu Y, Li M, Xu B. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production. PLoS ONE. 2020 Nov 02;15(11):e0240801. doi: 10.1371/journal.pone.0240801.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20774a8babf9d55d833d92da21ed565d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7312-8350 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_188430396a661c2bfda4968bed36b2d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_947c2910ca104d30b0bee4cb18d063f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b16b61d46a89ca7f1b3e1e9fa19893c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc995a2104f8a764e9e419a71526051e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f712fadc33749ecc10e6fd6d3720110 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d723fada76feda05c216b92f05357e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be7ab6b5853427b30b03df397a170188 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d12821334342b3c468783d7f38c98304
date	2020-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1371/journal.pone.0240801 https://pubmed.ncbi.nlm.nih.gov/33137125 https://pubmed.ncbi.nlm.nih.gov/PMC7605678
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production
discusses	http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0278815 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0017009 http://id.nlm.nih.gov/mesh/M0011238 http://id.nlm.nih.gov/mesh/M0012841 http://id.nlm.nih.gov/mesh/M0518021
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008243Q000235 http://id.nlm.nih.gov/mesh/D010972Q000378 http://id.nlm.nih.gov/mesh/D015854Q000187 http://id.nlm.nih.gov/mesh/D064129Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D064129Q000235 http://id.nlm.nih.gov/mesh/D007093Q000494 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D000078722 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017239Q000494 http://id.nlm.nih.gov/mesh/D002465Q000187 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D064129Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D007211Q000494 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d876b31399be575129188ea7b662c4f2 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154086 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108156 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2aec03df2a03fc399e135524c077f58d http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.1.47

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79888

Total number of triples: 68.